Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Advancing translational research and precision medicine with targeted proteomics.

Uzozie AC, Aebersold R.

J Proteomics. 2018 Oct 30;189:1-10. doi: 10.1016/j.jprot.2018.02.021. Epub 2018 Feb 22. Review.

PMID:
29476807
2.

Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.

Stepczynska A, Schanstra JP, Mischak H.

Bioanalysis. 2016;8(5):439-55. doi: 10.4155/bio.16.8. Epub 2016 Feb 19.

PMID:
26891752
3.

Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.

Azkargorta M, Soria J, Acera A, Iloro I, Elortza F.

J Proteomics. 2017 Jan 6;150:359-367. doi: 10.1016/j.jprot.2016.05.006. Epub 2016 May 13. Review.

PMID:
27184738
4.

Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.

Eckhard U, Marino G, Butler GS, Overall CM.

Biochimie. 2016 Mar;122:110-8. doi: 10.1016/j.biochi.2015.10.018. Epub 2015 Nov 14. Review.

5.

Multiplex assay for multiomics advances in personalized-precision medicine.

Popa ML, Albulescu R, Neagu M, Hinescu ME, Tanase C.

J Immunoassay Immunochem. 2019;40(1):3-25. doi: 10.1080/15321819.2018.1562940. Epub 2019 Jan 11. Review.

PMID:
30632882
6.

The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.

Alaaeddine R, Fayad M, Nehme E, Bahmad HF, Kobeissy F.

Adv Exp Med Biol. 2017;1007:59-70. doi: 10.1007/978-3-319-60733-7_4. Review.

PMID:
28840552
7.

Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.

Iliuk AB, Arrington JV, Tao WA.

Electrophoresis. 2014 Dec;35(24):3430-40. doi: 10.1002/elps.201400153. Epub 2014 Jul 10. Review.

8.

Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.

Manes NP, Nita-Lazar A.

J Proteomics. 2018 Oct 30;189:75-90. doi: 10.1016/j.jprot.2018.02.008. Epub 2018 Feb 13. Review.

9.

Revisiting biomarker discovery by plasma proteomics.

Geyer PE, Holdt LM, Teupser D, Mann M.

Mol Syst Biol. 2017 Sep 26;13(9):942. doi: 10.15252/msb.20156297. Review.

10.

Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.

Hawkridge AM, Muddiman DC.

Annu Rev Anal Chem (Palo Alto Calif). 2009;2:265-77. doi: 10.1146/annurev.anchem.1.031207.112942. Review.

11.

Translational -omics: Future potential and current challenges in precision medicine.

Wafi A, Mirnezami R.

Methods. 2018 Dec 1;151:3-11. doi: 10.1016/j.ymeth.2018.05.009. Epub 2018 May 22. Review.

PMID:
29792918
12.

Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.

Zhou L, Wang K, Li Q, Nice EC, Zhang H, Huang C.

Expert Rev Proteomics. 2016;13(4):367-81. doi: 10.1586/14789450.2016.1159959. Epub 2016 Mar 16. Review.

PMID:
26923776
13.

SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications.

Anjo SI, Santa C, Manadas B.

Proteomics. 2017 Feb;17(3-4). doi: 10.1002/pmic.201600278. Review.

PMID:
28127880
14.

Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.

Yocum AK, Chinnaiyan AM.

Brief Funct Genomic Proteomic. 2009 Mar;8(2):145-57. doi: 10.1093/bfgp/eln056. Epub 2009 Mar 11. Review.

15.

High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.

Lin L, Zheng J, Yu Q, Chen W, Xing J, Chen C, Tian R.

J Proteomics. 2018 Mar 1;174:9-16. doi: 10.1016/j.jprot.2017.12.014. Epub 2017 Dec 24.

PMID:
29278786
16.

Targeted mass spectrometry approaches for protein biomarker verification.

Meng Z, Veenstra TD.

J Proteomics. 2011 Nov 18;74(12):2650-9. doi: 10.1016/j.jprot.2011.04.011. Epub 2011 Apr 21. Review.

PMID:
21540133
17.

Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.

Collins BC, Hunter CL, Liu Y, Schilling B, Rosenberger G, Bader SL, Chan DW, Gibson BW, Gingras AC, Held JM, Hirayama-Kurogi M, Hou G, Krisp C, Larsen B, Lin L, Liu S, Molloy MP, Moritz RL, Ohtsuki S, Schlapbach R, Selevsek N, Thomas SN, Tzeng SC, Zhang H, Aebersold R.

Nat Commun. 2017 Aug 21;8(1):291. doi: 10.1038/s41467-017-00249-5.

18.

Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.

Cohen Freue GV, Meredith A, Smith D, Bergman A, Sasaki M, Lam KK, Hollander Z, Opushneva N, Takhar M, Lin D, Wilson-McManus J, Balshaw R, Keown PA, Borchers CH, McManus B, Ng RT, McMaster WR; Biomarkers in Transplantation and the NCE CECR Prevention of Organ Failure Centre of Excellence Teams.

PLoS Comput Biol. 2013 Apr;9(4):e1002963. doi: 10.1371/journal.pcbi.1002963. Epub 2013 Apr 4.

19.

Toward an integrated pipeline for protein biomarker development.

Drabovich AP, Martínez-Morillo E, Diamandis EP.

Biochim Biophys Acta. 2015 Jun;1854(6):677-86. doi: 10.1016/j.bbapap.2014.09.006. Epub 2014 Sep 11. Review.

PMID:
25218201
20.

Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.

Sajic T, Liu Y, Aebersold R.

Proteomics Clin Appl. 2015 Apr;9(3-4):307-21. doi: 10.1002/prca.201400117. Epub 2015 Feb 23. Review.

PMID:
25504613

Supplemental Content

Support Center